A Prospective, Observational Study in Patients With Late-Onset Pompe Disease

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

January 31, 2006

Conditions
Glycogen Storage Disease Type II
Trial Locations (5)

20010

Children's Hospital Medical Center, Washington D.C.

63110

School of Medicine, Campus Box 8111, St Louis

98105

Children's Hospital & Regional Medical Center, Seattle

CEDEX 13

Institut de Myologie, Groupe Hospitalier Pitie-Salpetriere, Batimant Babinski, Paris

3584CX

Universitair Medisch Centrum, Utrecht

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00077662 - A Prospective, Observational Study in Patients With Late-Onset Pompe Disease | Biotech Hunter | Biotech Hunter